Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Benjamin

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Cancer Treatment Reviews|February 25, 2025
Individualizing first-line treatment for advanced urothelial carcinoma: A favorable dilemma for patients and physiciansEnrique Grande, Syed A Hussain, Philippe Barthélémy, et al.
International Journal of Epidemiology|May 17, 2021
Chronic medical conditions and late effects after acute myeloid leukaemia in adolescents and young adults: a population-based studyRenata Abrahão, Jasmine C Huynh, David J Benjamin, et al.
Clinical Medicine Insights. Oncology|June 20, 2025
Evaluating Patient Adherence and Persistence to Tyrosine-Kinase Inhibitors for Metastatic Renal Cell Carcinoma: A Retrospective Analysis of Real-World DataZhaohui Liao Arter, David J Benjamin, Yen Cao, et al.
Cancer Treatment and Research Communications|January 7, 2026
Understanding Patient and Oncologist Preferences in the Management of Metastatic Renal Cell CarcinomaOmid Yazdanpanah, Aditya Mahadevan, David J Benjamin, et al.
NPJ Precision Oncology|January 11, 2025
Comprehensive analysis of targetable mutations and tumor microenvironment in urachal cancerDavid J Benjamin, Tolulope T Adeyelu, Andrew Elliott, et al.
Frontiers in Oncology|March 29, 2021
Outcomes of Adults With Relapsed/Refractory Acute Myeloid Leukemia Treated With Venetoclax Plus Hypomethylating Agents at a Comprehensive Cancer CenterMatthew E Tenold, Benjamin N Moskoff, David J Benjamin, et al.
Cancers|March 28, 2024
Characterization of Thyroid Cancer among Hispanics in California, USA, from 2010 to 2020Robert C Hsu, Kai-Ya Tsai, David J Benjamin, et al.
Antimicrobial Agents and Chemotherapy|December 19, 2018
Isavuconazole in the Treatment of Coccidioidal MeningitisArash Heidari, Miriam Quinlan, David J Benjamin, et al.
European Urology Open Science|January 5, 2023
Outcomes of Patients with Advanced Urothelial Carcinoma after Anti-programmed Death-(ligand) 1 Therapy by Fibroblast Growth Factor Receptor Gene Alteration Status: An Observational StudyArash Rezazadeh Kalebasty, David J Benjamin, Yohann Loriot, et al.
The Patient|August 28, 2024
Patient Preferences for First-Line Treatment of Locally Advanced or Metastatic Urothelial Carcinoma: An Application of Multidimensional ThresholdingAndrea B Apolo, Christine Michaels-Igbokwe, Nicholas I Simon, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Cancer Treatment Reviews|February 25, 2025
Individualizing first-line treatment for advanced urothelial carcinoma: A favorable dilemma for patients and physiciansEnrique Grande, Syed A Hussain, Philippe Barthélémy, et al.
International Journal of Epidemiology|May 17, 2021
Chronic medical conditions and late effects after acute myeloid leukaemia in adolescents and young adults: a population-based studyRenata Abrahão, Jasmine C Huynh, David J Benjamin, et al.
Clinical Medicine Insights. Oncology|June 20, 2025
Evaluating Patient Adherence and Persistence to Tyrosine-Kinase Inhibitors for Metastatic Renal Cell Carcinoma: A Retrospective Analysis of Real-World DataZhaohui Liao Arter, David J Benjamin, Yen Cao, et al.
Cancer Treatment and Research Communications|January 7, 2026
Understanding Patient and Oncologist Preferences in the Management of Metastatic Renal Cell CarcinomaOmid Yazdanpanah, Aditya Mahadevan, David J Benjamin, et al.
NPJ Precision Oncology|January 11, 2025
Comprehensive analysis of targetable mutations and tumor microenvironment in urachal cancerDavid J Benjamin, Tolulope T Adeyelu, Andrew Elliott, et al.
Frontiers in Oncology|March 29, 2021
Outcomes of Adults With Relapsed/Refractory Acute Myeloid Leukemia Treated With Venetoclax Plus Hypomethylating Agents at a Comprehensive Cancer CenterMatthew E Tenold, Benjamin N Moskoff, David J Benjamin, et al.
Cancers|March 28, 2024
Characterization of Thyroid Cancer among Hispanics in California, USA, from 2010 to 2020Robert C Hsu, Kai-Ya Tsai, David J Benjamin, et al.
Antimicrobial Agents and Chemotherapy|December 19, 2018
Isavuconazole in the Treatment of Coccidioidal MeningitisArash Heidari, Miriam Quinlan, David J Benjamin, et al.
European Urology Open Science|January 5, 2023
Outcomes of Patients with Advanced Urothelial Carcinoma after Anti-programmed Death-(ligand) 1 Therapy by Fibroblast Growth Factor Receptor Gene Alteration Status: An Observational StudyArash Rezazadeh Kalebasty, David J Benjamin, Yohann Loriot, et al.
The Patient|August 28, 2024
Patient Preferences for First-Line Treatment of Locally Advanced or Metastatic Urothelial Carcinoma: An Application of Multidimensional ThresholdingAndrea B Apolo, Christine Michaels-Igbokwe, Nicholas I Simon, et al.
Pageof 9